why sullivan university/university of louisville as main knowledge partners for knowledge...

Why Sullivan University/University of Louisville

asMain Knowledge Partners

forKnowledge City/University for Seamless

Learning and Research (USER)

You Know of Sullivan University

Capabilities

Expertise

Ability to Respond

Vision

Management

About the University of Louisville

Fastest growing university inNIH support

Growth built on solid strategic/business models

Community (Boyle Report)

State (Postsecondary Education Improvement Act)

Partnership (LMCDC – NUCLEUS)

Our Research Focus

Healthcare/Life Science Hearts Cancer Pediatrics

Birth Defects Ophthalmology Transplantation Neurosciences Homeland Security Infectious Diseases

Our Research Focus

Bioengineering

Logistics/Distribution Management/Systems

Entrepreneurship

Early Childhood/Brain Development

Our Research Emphasis

Translational Research

Creating Knowledge

Improve Quality of Life

Commercialization

Identify & Evaluate•LDG Sleep Therapeutics -Agreed to Partner 5/06•Orthopedic Products -Progress toward Partnership•Medical Imaging Products -Early stages of evaluation

Stage I: Create the Business

•BioInformatics/e-commerce - Progress toward incorporation•ImmunoTheragnostics - Agree to partner 5/06•ULSD Diagnostic/Therapeutic - Agreed to partnership and developed business model•Cardiovascular Device - Conceptual framework in development

Stage II:Prepare for Seed Funding •EndoProtech, Inc. - Received KSTC R&D Voucher Funding•InnoRem, Inc. - KSTC R&D Voucher InitiatedAllTranz, LLC - Partnership Formed•AsotaBio, Inc.*•Inflamed Inc.*

Stage III:Prime for A Round Investment

•Pradama Inc. - Raised $450K in seed funding•RhinoCyte, Inc. - Closing on $460K seed financing •Software Solutions Group Inc. - Securing significant venture capital financing•Ocular Transplantation LLC - Identifying strategic partners•Mindstreet, LLC - Proposal for partnership submitted

•3DR, Inc.•ApoImmune Inc.•Laboratory Partners, Inc.**•PGX Labs

*InflaMed, AsotaBio (founders have moved)**Funding in Place

Origination Launch

Compellingopportunity

Stage I Stage II

Begin seed fundingprocess

Prospecting

Approx. 4months

Approx. 4months

A Round

Possibleelimination point

IND510(k)

Seed Round

Possibleelimination point

Pre-clinical

Stage III

Approx. 12 months

MetaCyte begins the company creationprocess again with a new concept

Clinical*

U of L at a Glance

More than 205 majors, degree and certificate programs

13 academic and professional colleges

Enrollment totaled 21,760 (Fall 2005)

Chronicle of Higher Education cited U of L as fastest growing of Top 100 Institutions in NIH funding

Challenge for Excellence

Enhance education

Grow research

Promote partnerships

Be accountable

Encourage diversity

U of L’s Strategic Goals